Prompt Praxis Laboratories’ Ready‑to‑Analyze® Test Methods provide pharmacies and compounding facilities with rapid, pre-validated analytical testing solutions for key drug attributes—such as strength, purity, potency, identity, and quality. These ready-to-use methods support efficient turnaround with minimal additional validation needed, helping streamline compliance with regulatory standards for compounded medications.
Key Features:
- Comprehensive Pre-Validated Library: Offers a wide range of “ready-to-analyze” test protocols covering small molecules like antivirals, anesthetics, bronchodilators, and more.
- Rapid Turnaround: Validated over typical concentration ranges (1–50 µg/mL), the methods provide fast results that can be applied directly after a quick specificity check.
- Error-Reducing Automation: The fully digitalized lab infrastructure helps reduce manual error and accelerates testing through streamlined workflows.
- Regulatory Support for 503B and Compounders: By cutting validation time by 6–8 weeks, Ready‑to‑Analyze® methods help facilities achieve timely, compliant product release.
Adopting Ready‑to‑Analyze® Test Methods helps pharmacies meet regulatory demands swiftly, reduce operational bottlenecks, and maintain clinical quality—all without reinventing analytical workflows.
